The Global Neuromodulation Market is expected to exceed more than US$ 13.0 Billion by 2024 and will grow at a CAGR of more than 11% in the given forecast period.
You Browse Full Research Report @:https://www.marketresearchengine.com/reportdetails/neuromodulation-market-report
Neurological disorders which include epilepsy, alzheimer disorder, cerebrovascular sicknesses, and Parkinson’s disease have an effect on the critical and peripheral anxious machine. Bacterial, viral, and fungal infections also can reason neurological disorders. To manage such problems, neuromodulation is used; in which small electrodes generate electric most precise stimulation with the help of pulse generators to complement neurological activities in effected humans. The electrodes are normally located without delay within the mind or peripheral nerves or spinal twine while pulse mills are implanted within the pores and skin.
The Global Neuromodulation Market is segmented on the lines of its technology, application and biomaterial. Technology segmentation is further classified into internal neuromodulation and external neuromodulation. Based on internal neuromodulation segmentation it covers deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation and other neuromodulation technologies. External neuromodulation is classified into transcranial magnetic stimulation and transcutaneous electrical nerve stimulation. Based on application segmentation it covers chronic pain management, tremor, failed back syndrome, epilepsy, depression, urinary and fecal incontinence, dystonia, obsessive compulsive, disorder, gastroparesis, migraine, parkinson’s disease and other applications. Under biomaterial segmentation it covers polymeric biomaterials, metallic biomaterials and ceramic biomaterials. The Global Neuromodulation market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Medtronic plc, St. Jude Medical, Inc., LivaNova PLC, Boston Scientific Corporation, Aleva Neurotherapeutics SA, BioControl Medical, Bioness Inc., EnteroMedics Inc., Nevro Corporation and NeuroPace Inc. Company profile includes assign such as company summary, financial summary,business strategy and planning, SWOT analysis and current developments.
This report provides:
1) An overview of the global market for Global Neuromodulation and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Global Neuromodulation Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The scope of the report includes a detailed study of global and regional markets for Global Neuromodulation Market with the reasons given for variations in the growth of the industry in certain regions.
The restraining factors of Global Neuromodulation Market are as follows:
- Stringent approval policies
• Lack of trained healthcare professionals
The major driving factors of Global Neuromodulation Market are as follows:
- Increase in geriatric population
• Rise in awareness regarding the efficacy and safety of neurostimulator devices.
• Growing incidence of neurological diseases
The Global Neuromodulation Market has been segmented as below:
The Global Neuromodulation Market is Segmented on the lines of Biomaterial Analysis, Technology Analysis, Application Analysis and Regional Analysis.By Biomaterial Analysisthis market is segmented on the basis ofPolymeric Biomaterials, Metallic Biomaterials and Ceramic Biomaterials. By Technology Analysisthis market is segmented on the basis ofInternal neuromodulation its covers Deep Brain Stimulation, Spinal Cord Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation&Other Neuromodulation Technologies. External neuromodulation its covers Transcranial Magnetic Stimulation&Transcutaneous Electrical Nerve Stimulation.
By Application Analysisthis market is segmented on the basis ofChronic Pain Management, Tremor, Failed back syndrome, Epilepsy, Depression, Urinary and Fecal Incontinence, Dystonia, Obsessive-Compulsive Disorder, Gastroparesis, Migraine, Parkinson’s disease and Other Applications. By Regional Analysisthis market is segmented on the basis ofNorth America, Europe, Asia-Pacific and Rest of the World.
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Neuromodulation Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Neuromodulation Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Request Sample Report from here:https://www.marketresearchengine.com/reportdetails/neuromodulation-market-report
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Global Neuromodulation Market, By Technology
6.2 Internal Neuromodulation
6.2.1 Spinal Cord Stimulation (SCS)
6.2.2 Deep Brain Stimulation (DBS)
6.2.3 Vagus Nerve Stimulation (VNS)
6.2.4 Sacral Nerve Stimulation (SNS)
6.2.5 Gastric Electrical Stimulation (GES)
6.3 External Neuromodulation (Non-Invasive)
6.3.1 Transcutaneous Electrical Nerve Stimulation (Tens)
6.3.2 Transcranial Magnetic Stimulation (TMS)
6.3.3 Respiratory Electrical Stimulation (RES)
7 Global Neuromodulation Market, By Application
8 Neuromodulation Market, By Region
9 Competitive Landscape
10 Company Profiles
10.2 Medtronic, Inc.
10.3 Boston Scientific Corporation
10.4 ST. Jude Medical, Inc.
10.5 Cyberonics, Inc.
10.6 Nevro Corporation
10.7 Neurosigma, Inc.
10.8 Neuropace, Inc.
10.9 Biocontrol Medical
10.10 Synapse Biomedical, Inc.
10.11 Neuronetics, Inc.
Company Name: Market Research Engine
Contact Person: John Bay
Email: [email protected]
Country: United States